STRAIN OF ASIDIOMYCETE DAEDALEOPSIS CONFRAGOSA, CONTAINING PROTEINS, EXHIBITING ANTICANCER AND ANTIVIRAL ACTIVITY Russian patent published in 2018 - IPC C12N1/14 A61K36/06 

FIELD: biotechnology.

SUBSTANCE: invention relates to biotechnology. Strain of basidiomycete Daedaleopsis confragosa K-1326, which has cytostatic anticancer activity against human marrow myeloma (IM-9), human lymphadenoma (Namalva) and inhibitory activity against herpes simplex virus type 2, influenza virus A / H1N1 / California / 2009, is deposited in the Collection of bacteria, bacteriophages and fungi of the Federal State-Funded Institution SSC SRB WB “Vektor” of Federal Supervision Agency for Customer Protection and Human Welfare under the registration number F-1368. Strain of basidiomycete Daedaleopsis confragosa can be used to produce anticancer and antiviral drugs.

EFFECT: invention allows to increase yield of proteins exhibiting activity against tumor cells and viruses that are pathogenic to human.

1 cl, 4 dwg, 4 tbl, 6 ex